Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as ...

Professor Kwang-Hyun Cho's research team of the Department of Bio and Brain Engineering at KAIST has captured the critical ...

The launch coincides with March Colorectal Cancer Awareness Month, a global initiative emphasizing the importance of early ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...

This collaboration will streamline the ordering and delivery of molecular tests, enabling healthcare providers to electronically order and track Prolaris and MyRisk tests, with results delivered ...

Issuer: Mainz Biomed N.V. / Key word (s): Miscellaneous Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month 11.02.2025 / 14:01 ...

Scientists have found a molecular switch that reverses cancer cells in the body back to their normal, healthy state.

Professor Kwang-Hyun Cho's research team has recently been highlighted for their work on developing an original technology ...

"We have discovered a molecular switch that can revert the fate of cancer cells," said biologist Kwang-Hyun Cho.

The research team led by Professor Kwang-Hyun Cho of KAIST Bio and Brain Engineering who recently announce "Cancer Reversion ...

Scientists have discovered a way to turn cancer cells back into healthy cells. This breakthrough comes from researchers at ...